YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,Response,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,StratificationCategory2,Stratification2,StratificationCategory3,Stratification3,GeoLocation,ResponseID,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1,StratificationCategoryID2,StratificationID2,StratificationCategoryID3,StratificationID3
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,9.9,11.5,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,7.7,9.0,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.6,10.6,,,8.3,13.5,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,74.3,88.2,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.4,50.4,,,41.5,59.2,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,8.2,10.1,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.5,73.5,,,68.0,78.5,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,63.4,85.0,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.7,90.7,,,84.2,94.7,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.8,11.8,,,10.9,12.7,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.6,11.6,,,9.3,14.5,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.9,8.9,,,7.8,10.1,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.9,45.9,,,38.5,53.6,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.4,74.4,,,62.5,83.5,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.0,9.0,,,7.9,10.2,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.1,68.1,,,57.8,76.9,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.2,35.2,,,27.5,43.7,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.0,26.0,,,20.2,32.8,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.2,65.2,,,54.1,74.9,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.7,79.7,,,70.8,86.5,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,57.3,57.3,,,43.4,70.2,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.1,13.1,,,10.4,16.6,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.9,12.9,,,9.9,16.6,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,29.6,46.8,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.0,10.0,,,8.8,11.4,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.7,39.7,,,32.3,47.7,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.8,76.8,,,66.6,84.6,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.1,10.1,,,8.9,11.3,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,60.4,60.4,,,47.9,71.7,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.1,71.1,,,57.7,81.7,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.7,36.7,,,29.5,44.6,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.1,46.1,,,38.4,54.0,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.9,27.9,,,21.6,35.3,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.8,82.8,,,74.8,88.7,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.8,63.8,,,54.2,72.4,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.5,36.5,,,29.1,44.6,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,25.5,41.3,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.1,64.1,,,54.6,72.6,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,9.1,16.6,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,7.9,10.5,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.8,81.8,,,73.1,88.2,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.0,9.0,,,7.9,10.3,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,26.4,42.1,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,29.8,46.1,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.8,66.8,,,58.8,74.0,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,8.6,10.2,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,30.2,40.4,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,32.1,41.9,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,32.0,41.5,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,10.4,14.6,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.7,40.1,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.5,9.5,,,8.7,10.3,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.8,65.8,,,57.6,73.1,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.8,81.8,,,73.6,87.9,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.8,8.8,,,7.9,9.7,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.8,74.8,,,63.2,83.7,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,7.9,9.7,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.4,67.4,,,56.2,76.9,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,30.1,42.2,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.5,74.5,,,62.7,83.5,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,34.6,46.2,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.4,68.4,,,57.3,77.7,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.0,41.0,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.7,10.7,,,8.8,13.1,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,33.7,44.8,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.4,10.4,,,9.7,11.1,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.5,53.5,,,49.2,57.7,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,35.5,44.4,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,9.7,11.2,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,48.5,56.9,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,34.4,43.6,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.7,88.7,,,82.0,93.2,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.4,13.4,,,11.7,15.3,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.3,76.3,,,68.4,82.7,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.9,88.9,,,82.4,93.1,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.6,74.6,,,65.7,81.8,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.7,64.7,,,52.2,75.5,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.0,86.0,,,79.0,91.0,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.3,53.3,,,47.8,58.8,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,25.9,36.2,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.4,52.4,,,47.1,57.6,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,9.8,11.7,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,25.2,35.7,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,9.6,11.5,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.8,85.8,,,78.4,90.9,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.8,13.8,,,11.6,16.4,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.2,65.2,,,51.9,76.4,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.2,24.2,,,18.8,30.6,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.6,11.6,,,10.1,13.3,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.1,50.1,,,41.4,58.8,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.8,72.8,,,58.4,83.7,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.6,78.6,,,64.0,88.4,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.1,23.1,,,17.4,30.0,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.7,71.7,,,57.2,82.8,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.1,79.1,,,64.9,88.6,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.9,14.9,,,11.6,18.9,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.8,11.8,,,10.2,13.6,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,,,8.6,11.3,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.2,30.2,,,22.6,39.1,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,40.0,57.4,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.4,13.4,,,10.0,17.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.7,81.7,,,68.6,90.1,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.2,76.2,,,62.9,85.8,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.5,28.5,,,20.9,37.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.7,47.7,,,38.8,56.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.7,85.7,,,76.4,91.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.7,77.7,,,64.5,87.1,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.2,10.2,,,8.7,11.8,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.3,40.6,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,33.1,45.1,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.1,65.1,,,55.2,73.8,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.3,78.3,,,68.2,85.8,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.7,79.7,,,71.0,86.3,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.6,4.6,,,3.3,6.3,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.1,65.1,,,55.4,73.7,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.5,9.5,,,8.5,10.6,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,8.4,10.4,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.5,28.5,,,16.2,45.1,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,31.4,44.0,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.8,14.8,,,12.2,17.8,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,16.7,47.2,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.7,4.7,,,3.4,6.5,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,28.0,40.9,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.1,8.1,,,7.3,9.0,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.3,10.3,,,8.4,12.6,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.1,8.1,,,7.3,9.0,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,37.4,49.9,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.0,29.0,,,23.0,35.8,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.5,72.5,,,62.5,80.6,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.9,71.9,,,59.3,81.8,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.4,71.4,,,57.7,82.0,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.4,72.4,,,62.3,80.6,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.4,43.4,,,37.3,49.6,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.2,28.2,,,22.7,34.5,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,,,39.1,50.4,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,44.4,55.2,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.2,77.2,,,69.4,83.5,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.5,87.5,,,81.3,91.8,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,8.4,10.0,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.9,49.9,,,44.4,55.4,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.2,46.2,,,40.5,51.9,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.6,12.6,,,10.4,15.1,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.2,77.2,,,69.4,83.5,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.4,87.4,,,81.2,91.8,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.3,9.3,,,8.5,10.2,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.0,12.0,,,9.8,14.6,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.8,70.8,,,62.0,78.3,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.7,83.7,,,75.0,89.8,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,,,8.9,10.7,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,30.8,41.9,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,27.8,39.4,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.7,9.7,,,8.8,10.7,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.1,36.1,,,30.7,41.7,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.7,31.7,,,26.3,37.8,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.7,70.7,,,62.2,77.9,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.6,13.6,,,12.1,15.2,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.3,83.3,,,74.9,89.3,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.7,8.7,,,7.4,10.2,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.4,83.4,,,68.3,92.2,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.5,84.5,,,70.1,92.7,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.3,38.3,,,28.9,48.7,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.2,81.2,,,64.0,91.3,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.0,45.0,,,35.8,54.5,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.2,85.2,,,70.1,93.4,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.3,44.3,,,35.8,53.2,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,29.5,49.0,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.7,11.7,,,8.4,16.0,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.8,8.8,,,7.5,10.4,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.1,69.1,,,62.0,75.4,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.8,85.8,,,80.3,90.0,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.0,70.0,,,62.5,76.5,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.2,86.2,,,80.6,90.4,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.1,41.1,,,36.6,45.8,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,30.9,40.4,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,29.5,39.1,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,36.2,45.1,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.3,10.3,,,9.6,11.1,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.4,10.4,,,9.6,11.2,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.1,15.1,,,13.1,17.3,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,10.0,11.3,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.1,82.1,,,76.8,86.4,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.6,10.6,,,10.0,11.2,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.4,46.4,,,42.9,49.9,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.3,74.3,,,68.7,79.2,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,37.0,44.2,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.4,82.4,,,77.0,86.8,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.3,45.3,,,42.0,48.7,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,34.9,41.8,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.9,14.9,,,12.1,18.4,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.0,70.0,,,59.5,78.8,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.3,74.3,,,63.5,82.8,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.4,69.4,,,58.8,78.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,10.6,12.9,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.5,75.5,,,65.5,83.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.6,11.6,,,10.5,12.9,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,30.8,43.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,27.0,39.2,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,31.9,43.8,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.8,35.8,,,29.8,42.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.8,9.8,,,8.6,11.1,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,27.6,41.5,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,27.8,41.2,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.9,34.9,,,28.4,42.0,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.7,75.7,,,64.7,84.1,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,8.6,10.9,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.9,83.9,,,71.3,91.6,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.2,78.2,,,68.9,85.4,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.7,31.7,,,25.6,38.4,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,9.7,15.7,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.1,86.1,,,75.5,92.6,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.7,12.7,,,10.9,14.8,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.1,85.1,,,79.6,89.3,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.4,74.4,,,67.9,80.0,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,8.7,10.1,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,28.2,39.2,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.6,46.6,,,41.9,51.3,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,28.8,37.6,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.4,61.4,,,56.2,66.3,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.6,75.6,,,63.4,84.7,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.8,90.8,,,83.4,95.0,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.0,87.0,,,78.0,92.7,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,,,27.7,36.8,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.5,45.5,,,40.7,50.4,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.7,11.7,,,10.7,12.8,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.1,73.1,,,66.3,78.9,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.7,59.7,,,54.6,64.6,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.1,84.1,,,77.9,88.8,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,27.6,38.7,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.4,9.4,,,8.7,10.1,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,10.7,12.8,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.9,16.9,,,14.4,19.8,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,33.7,44.2,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.5,85.5,,,80.2,89.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.6,45.6,,,40.5,50.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.1,78.1,,,72.6,82.8,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.8,46.8,,,42.0,51.7,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,37.5,47.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,18.4,18.4,,,15.7,21.5,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,,,11.6,13.4,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.9,12.9,,,11.8,14.0,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,73.5,83.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.5,86.5,,,81.4,90.4,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.6,15.6,,,13.4,18.1,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.1,72.1,,,64.6,78.5,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.5,11.5,,,10.7,12.4,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.7,71.7,,,63.6,78.6,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.0,45.0,,,40.2,49.9,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.6,85.6,,,80.1,89.8,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.1,41.1,,,36.2,46.1,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.0,85.0,,,79.5,89.2,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,34.9,44.9,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.9,43.9,,,39.3,48.7,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.7,38.7,,,34.9,42.7,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.6,75.6,,,69.4,80.9,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.2,53.2,,,49.2,57.1,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.9,8.9,,,8.3,9.5,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.2,75.2,,,68.5,80.8,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.8,37.8,,,34.0,41.8,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.5,87.5,,,82.5,91.1,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.9,52.9,,,48.9,56.9,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.6,87.6,,,82.8,91.3,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,8.2,9.3,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.9,12.9,,,11.3,14.6,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.6,82.6,,,73.5,89.1,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.7,69.7,,,61.0,77.2,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.4,9.4,,,8.6,10.3,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.4,83.4,,,74.2,89.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.4,70.4,,,61.3,78.1,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.7,9.7,,,8.8,10.6,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.4,43.4,,,38.3,48.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.7,13.7,,,11.6,16.2,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,35.0,45.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,8.8,10.7,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.7,38.7,,,33.5,44.2,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,38.3,48.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.2,71.2,,,59.7,80.4,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.0,68.0,,,56.6,77.7,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,26.3,26.3,,,20.4,33.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,26.5,40.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.3,12.3,,,9.4,15.9,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,8.7,11.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.7,24.7,,,19.0,31.5,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.0,10.0,,,8.8,11.4,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.2,33.2,,,26.6,40.7,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.7,72.7,,,61.9,81.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.6,66.6,,,55.2,76.4,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,34.4,46.8,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.9,41.9,,,35.9,48.0,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.6,75.6,,,67.6,82.2,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.1,90.1,,,84.0,94.1,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.0,10.0,,,9.0,11.1,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.6,41.6,,,35.8,47.7,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,33.9,46.1,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.7,89.7,,,83.3,93.8,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.1,14.1,,,11.4,17.3,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.9,74.9,,,66.8,81.7,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.8,67.8,,,54.8,78.5,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.3,87.3,,,78.3,92.9,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,33.2,48.3,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,37.1,51.0,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.6,66.6,,,53.1,77.9,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.7,8.7,,,7.7,9.7,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.6,8.6,,,7.6,9.7,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,36.7,50.6,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,,,31.2,46.2,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.6,79.6,,,71.4,85.9,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.4,8.4,,,7.5,9.4,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.5,51.5,,,44.7,58.3,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.7,79.7,,,71.6,86.0,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.5,8.5,,,7.5,9.6,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.8,45.8,,,38.7,53.1,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,42.4,57.1,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.9,44.9,,,37.2,52.7,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.6,83.6,,,75.0,89.6,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.7,83.7,,,75.1,89.7,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,34.2,44.1,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.0,54.0,,,48.9,58.9,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.7,85.7,,,79.1,90.4,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.5,70.5,,,63.5,76.6,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.8,82.8,,,76.5,87.7,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.1,12.1,,,11.0,13.3,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.2,8.2,,,7.6,8.9,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.6,39.6,,,34.7,44.8,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.5,87.5,,,82.8,91.0,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.1,54.1,,,49.1,59.1,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,11.1,13.7,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.4,33.4,,,26.9,40.6,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.0,50.0,,,43.4,56.6,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,16.9,16.9,,,13.6,20.9,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,11.8,11.8,,,10.1,13.7,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.6,70.6,,,63.8,76.6,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.3,81.3,,,74.5,86.6,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.2,87.2,,,82.7,90.6,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.2,84.2,,,77.4,89.3,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.3,36.3,,,30.0,43.2,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.4,51.4,,,44.9,57.9,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.1,52.1,,,45.5,58.5,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.9,32.9,,,25.9,40.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.3,77.3,,,66.3,85.6,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.6,70.6,,,59.6,79.6,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.3,70.3,,,60.1,78.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.9,8.9,,,8.1,9.9,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,25.2,38.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.0,52.0,,,45.7,58.2,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,8.2,10.1,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.4,14.4,,,11.7,17.5,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.2,77.2,,,67.3,84.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.4,44.4,,,38.3,50.6,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.5,15.5,,,12.8,18.6,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.7,85.7,,,79.5,90.3,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,36.1,48.9,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,9.5,11.7,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.2,72.2,,,63.1,79.8,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,38.1,50.7,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.8,42.8,,,36.4,49.4,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.0,87.0,,,81.5,91.0,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.6,10.6,,,9.6,11.7,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.4,73.4,,,64.5,80.7,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.3,64.3,,,43.1,81.0,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.1,77.1,,,53.5,90.7,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.1,9.1,,,7.7,10.8,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,59.0,59.0,,,41.9,74.1,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.7,80.7,,,63.7,90.8,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.6,38.6,,,28.9,49.4,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,23.1,44.2,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.5,36.5,,,27.0,47.3,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.2,31.2,,,21.7,42.7,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.5,10.5,,,6.9,15.6,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.2,9.2,,,7.6,11.0,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,41.7,48.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.4,66.4,,,59.9,72.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.4,69.4,,,62.5,75.6,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,30.5,37.0,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.3,70.3,,,63.5,76.3,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,9.3,10.5,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.5,66.5,,,60.2,72.2,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.0,12.0,,,10.6,13.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,,,9.3,10.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.3,32.3,,,29.2,35.6,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.0,44.0,,,40.6,47.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.1,15.1,,,13.1,17.4,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,33.1,42.4,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.0,44.0,,,39.5,48.5,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.4,10.4,,,9.7,11.2,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.1,85.1,,,79.2,89.5,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.0,70.0,,,62.8,76.4,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.8,84.8,,,78.2,89.7,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.5,72.5,,,65.0,78.9,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,34.9,44.1,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.6,42.6,,,38.2,47.2,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.5,34.5,,,29.3,40.0,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.4,77.4,,,69.3,83.8,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.0,85.0,,,77.8,90.2,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,26.0,37.2,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.9,10.9,,,9.9,12.0,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,9.9,12.1,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,27.0,38.9,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,29.7,40.9,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.6,77.6,,,69.7,83.9,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.0,85.0,,,77.8,90.2,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.5,14.5,,,12.0,17.4,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.3,11.3,,,10.3,12.4,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.4,14.4,,,12.2,17.1,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.8,90.8,,,84.7,94.6,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.0,70.0,,,58.5,79.4,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.4,71.4,,,60.7,80.1,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,44.4,55.3,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.7,91.7,,,86.0,95.1,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,37.0,48.6,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.1,48.1,,,42.8,53.4,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,10.2,12.2,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.5,41.5,,,35.7,47.5,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,9.6,11.8,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,73.1,88.8,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.0,37.0,,,31.3,43.1,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.9,45.9,,,40.3,51.7,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.0,82.0,,,73.9,88.0,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.2,15.2,,,12.6,18.3,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.3,10.3,,,9.4,11.3,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.5,38.5,,,32.7,44.6,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,40.7,52.4,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.1,83.1,,,75.4,88.7,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.1,83.1,,,74.7,89.1,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.3,51.3,,,44.9,57.7,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.3,50.3,,,44.1,56.5,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,53.4,53.4,,,41.0,65.4,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,56.6,56.6,,,44.8,67.8,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.7,12.7,,,11.4,14.0,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.1,70.1,,,60.0,78.7,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.6,12.6,,,11.5,13.9,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,17.7,17.7,,,13.4,23.1,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.1,13.1,,,10.4,16.4,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.2,14.2,,,11.5,17.3,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.6,29.6,,,23.6,36.4,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.4,11.4,,,10.1,12.7,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,54.7,54.7,,,42.2,66.6,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.3,11.3,,,10.1,12.8,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,19.6,19.6,,,14.8,25.5,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.8,69.8,,,59.8,78.2,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,23.8,36.2,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,53.8,53.8,,,40.4,66.7,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.6,69.6,,,61.6,76.6,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,34.9,47.1,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.6,84.6,,,79.2,88.9,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.2,32.2,,,26.0,39.0,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.9,86.9,,,78.1,92.5,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.2,9.2,,,8.3,10.1,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.5,69.5,,,62.0,76.0,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,27.4,39.2,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,28.9,41.3,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,34.0,46.3,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.2,83.2,,,77.2,87.8,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.7,86.7,,,78.2,92.2,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.3,33.3,,,27.7,39.4,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.3,10.3,,,8.1,12.9,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.3,87.3,,,74.7,94.1,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,57.0,57.0,,,45.9,67.4,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.4,90.4,,,78.7,96.0,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.1,88.1,,,76.9,94.3,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,10.5,10.5,,,7.3,15.0,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,30.5,53.2,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,6.9,10.1,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.3,8.3,,,6.9,10.0,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,29.0,49.2,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.6,56.6,,,46.8,65.9,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.1,90.1,,,77.6,96.0,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.1,45.1,,,38.4,52.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,30.3,44.5,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,38.3,52.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.3,10.3,,,9.2,11.6,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.5,81.5,,,72.5,88.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.3,41.3,,,34.2,48.7,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.9,90.9,,,83.6,95.1,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.6,90.6,,,83.0,95.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.4,10.4,,,9.2,11.7,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.9,79.9,,,69.6,87.3,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.0,13.0,,,10.4,16.1,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,9.9,9.9,,,8.0,12.1,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.5,40.5,,,34.4,47.0,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,24.6,35.6,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.3,87.3,,,80.8,91.9,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.4,8.4,,,7.5,9.3,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,36.4,49.2,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.8,71.8,,,63.0,79.1,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,28.4,41.8,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.3,8.3,,,7.5,9.2,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.2,88.2,,,81.8,92.6,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.8,71.8,,,62.7,79.4,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,**,US estimate/number is based on fewer than 50 states and the District of Columbia,43.4,47.7,Overall,Overall,,,,,,,59,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.0,47.0,,,42.7,51.4,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.8,71.8,**,US estimate/number is based on fewer than 50 states and the District of Columbia,70.5,75.6,Overall,Overall,,,,,,,59,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,9.0,10.5,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,31.6,40.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,**,US estimate/number is based on fewer than 50 states and the District of Columbia,9.6,10.6,Overall,Overall,,,,,,,59,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.0,35.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,32.9,37.8,Overall,Overall,,,,,,,59,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.7,9.7,,,9.0,10.4,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,**,US estimate/number is based on fewer than 50 states and the District of Columbia,9.4,10.4,Overall,Overall,,,,,,,59,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.0,37.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,34.8,39.9,Overall,Overall,,,,,,,59,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.4,13.4,**,US estimate/number is based on fewer than 50 states and the District of Columbia,12.7,14.2,Overall,Overall,,,,,,,59,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.4,12.4,,,10.8,14.3,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.1,87.1,,,81.2,91.4,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.1,85.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,83.4,86.2,Overall,Overall,,,,,,,59,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.2,76.2,,,69.2,82.0,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.0,46.0,,,41.5,50.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.9,71.9,**,US estimate/number is based on fewer than 50 states and the District of Columbia,70.0,74.9,Overall,Overall,,,,,,,59,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.2,76.2,,,69.0,82.2,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.7,87.7,,,81.8,91.8,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.7,35.7,,,31.2,40.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.1,84.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,82.6,85.7,Overall,Overall,,,,,,,59,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,43.6,48.7,Overall,Overall,,,,,,,59,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.9,9.9,,,9.0,10.7,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.5,39.5,,,34.2,45.2,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.5,48.5,,,43.2,53.9,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.8,9.8,,,9.0,10.6,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,12.8,12.8,,,10.8,15.1,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.2,72.2,,,64.0,79.2,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.0,85.0,,,77.8,90.2,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,35.3,45.9,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,44.3,54.7,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.9,85.9,,,78.9,90.8,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.3,72.3,,,63.6,79.7,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.4,35.4,,,21.7,52.0,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.3,5.3,,,3.5,7.8,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.0,5.0,,,3.3,7.4,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.3,50.3,,,43.7,56.8,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.1,49.1,,,42.6,55.7,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,34.2,47.9,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.2,82.2,,,75.2,87.6,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.7,86.7,,,80.2,91.4,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.1,12.1,,,10.9,13.5,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.7,15.7,,,12.5,19.6,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.4,80.4,,,72.5,86.5,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.7,9.7,,,8.5,11.1,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.7,87.7,,,81.6,92.0,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.8,11.8,,,10.6,13.0,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,31.1,44.9,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.4,77.4,,,72.0,82.1,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.5,41.5,,,36.9,46.3,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.0,49.0,,,44.7,53.4,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.5,87.5,,,83.0,91.0,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,9.8,11.3,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.2,14.2,,,12.4,16.3,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,37.7,46.5,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.5,10.5,,,9.8,11.2,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.4,77.4,,,71.6,82.3,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.1,88.1,,,83.4,91.5,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,45.2,54.1,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.8,10.8,,,9.7,12.0,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.7,82.7,,,73.4,89.2,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.4,76.4,,,68.0,83.1,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.9,52.9,,,45.8,59.9,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.4,48.4,,,40.9,56.0,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,43.0,57.1,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.6,51.6,,,44.7,58.4,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.1,76.1,,,67.6,83.0,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,14.7,14.7,,,11.6,18.5,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.6,82.6,,,73.5,89.0,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,9.5,11.9,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,11.2,13.4,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,15.9,15.9,,,13.2,18.9,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.8,35.8,,,30.9,41.0,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.5,80.5,,,73.8,85.7,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.7,38.7,,,33.7,43.9,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,35.5,45.5,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.6,40.6,,,35.5,45.9,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.4,81.4,,,74.5,86.7,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.7,65.7,,,58.0,72.6,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.3,65.3,,,58.0,71.8,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.1,12.1,,,11.1,13.1,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,29.3,46.9,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.6,9.6,,,8.3,11.0,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.0,32.0,,,24.6,40.4,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Asthma prevalence among women aged 18-44 years,,%,Crude Prevalence,13.3,13.3,,,9.8,18.0,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,62.5,62.5,,,51.3,72.6,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.6,70.6,,,58.1,80.6,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.9,70.9,,,58.4,80.8,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,25.2,41.3,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,23.0,37.8,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,62.9,62.9,,,51.2,73.3,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,OVERALL,OVR,,,,
